Tradestie Institutional Equity Comparison Engine
SYK vs TMO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SYK Overall Edge
SYK Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Stryker Corporation (SYK) driven by superior Valuation, Growth & Margin, Options & Structure while TMO counters with relative strength in Momentum & Technical. Fundamentally, SYK trades at 19.0x Forward P/E with 24.0% operating margin (+7.6% YoY revenue) versus TMO at 25.2x Forward P/E and 19.1% operating margin (+9.1% YoY). In options structure, SYK sits in SURGE (5th %ile IV; Dealer Gamma Walls on Pro) against TMO sits in CONSOLIDATION (4th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
SYK
SYK 19.0x vs TMO 25.2x Fwd P/E
Growth & Margin Winner
SYK
Op Margin 24.0% vs 19.1% ยท YoY +7.6% vs +9.1%
Momentum & Technical Winner
TMO
1Y -16.8% vs +19.6% ยท 52W Pos 36% vs 88%
Options & Structure Winner
SYK
SURGE (5th %ile IV) vs CONSOLIDATION (4th %ile IV)
SYK
NYSE
Stryker Corporation
Surgical & Medical Instruments & Apparatus
$310.79
+0.37% 1D
Market Cap
$118.9B
1M Return
+5.47%
1Y Return
-16.77%
Forward P/E
19.0x
Unified AI Score
46.5 / 100
HOLD
Tech 37.0
Fund 49.0
Flow 58.0
Mom 60.0
TMO
NYSE
Thermo Fisher Scientific, Inc.
Measuring & Controlling Devices, Nec
$693.73
-0.93% 1D
Market Cap
$259.2B
1M Return
+0.54%
1Y Return
+19.58%
Forward P/E
25.2x
Unified AI Score
48.6 / 100
HOLD
Tech 35.0
Fund 47.0
Flow 57.0
Mom 41.8
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SYK -16.77%
TMO +19.58%
Spread: +36.35 pp (TMO Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SYK Revenue | TMO Revenue | SYK Op. Margin | TMO Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $13.6B | $24.4B | 18.7% | 15.5% | SYK |
| FY2019 | $14.9B | $25.5B | 18.2% | 18.0% | SYK |
| FY2020 | $14.3B | $32.2B | 15.5% | 24.2% | TMO |
| FY2021 | $17.1B | $39.2B | 15.1% | 25.6% | TMO |
| FY2022 | $18.4B | $44.9B | 15.4% | 18.7% | TMO |
| FY2023 | $20.5B | $42.9B | 19.0% | 16.0% | SYK |
| FY2024 | $22.6B | $42.9B | 16.3% | 17.1% | TMO |
| FY2025 | $25.1B | $44.6B | 19.5% | 17.4% | SYK |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SYK | TMO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $118.9B | $259.2B | Larger Scale | TMO |
| Trailing P/E Ratio Valuation | 33.3x | 36.9x | Lower Multiple | SYK |
| Forward P/E Ratio Valuation | 19.0x | 25.2x | Lower Multiple | SYK |
| Revenue Growth (YoY) Growth | +7.6% | +9.1% | Higher Growth | TMO |
| Operating Margin (TTM) Profitability | 24.0% | 19.1% | Higher Margin | SYK |
| Net Profit Margin Profitability | 13.8% | 14.9% | Higher Margin | TMO |
| Return on Equity (ROE) Capital Efficiency | 16.0% | 13.4% | Higher ROE | SYK |
| 52-Week Range Position Momentum | 36% ($267โ$389) | 88% ($435โ$728) | Stronger Trend | TMO |
| Beta / 30D Volatility Risk Regime | 0.22ฮฒ ยท 50% Vol | 0.61ฮฒ ยท 31% Vol | Lower Realized Risk | TMO |
| Unified Institutional Score Composite Signal | 46.5 / 100 (HOLD) | 48.6 / 100 (HOLD) | Higher Composite | TMO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SYK vs TMO Buy Guide
SYK
SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
TMO
CONSOLIDATION
44d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
4th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SYK nor TMO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.